About this trial
This is a prospective, observational cohort study of pediatric patients ages 2-12 undergoing radiation therapy at MD Anderson Cancer Center.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Provision of signed and dated informed consent from a parent or legal guardian.
For children age 7 and older, provision of informed assent in addition to parental consent, consistent with institutional guidelines.
Stated willingness of parent/guardian and child (as appropriate) to comply with study procedures (i.e., observation during scheduled radiation therapy appointments).
Male or female, ages 2-12 years.
Disqualifiers
Has already completed the simulation session for radiation therapy prior to enrollment.
Declines parental consent or, when applicable, child assent.
Trial population
UT MD Anderson patients
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Safety and Adverse Events (AEs)
Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0
Sponsors and contacts
Click on the lead sponsor to view all of their trials.